• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 5. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli

Introduction to 4-(3,5-Dichlorophenyl)-2-fluorobenzaldehyde (CAS No. 1361871-90-0)

4-(3,5-Dichlorophenyl)-2-fluorobenzaldehyde, identified by the Chemical Abstracts Service Number (CAS No.) 1361871-90-0, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of arylaldehydes, characterized by the presence of a benzaldehyde moiety appended to a substituted aromatic ring. The structural features of 4-(3,5-Dichlorophenyl)-2-fluorobenzaldehyde, particularly the combination of chlorine and fluorine substituents on the phenyl ring, contribute to its unique electronic and steric properties, making it a valuable scaffold for the development of novel bioactive molecules.

The significance of this compound lies in its potential applications as an intermediate in the synthesis of pharmacologically active agents. Arylaldehydes are well-documented intermediates in drug discovery, often serving as key building blocks for molecules targeting various biological pathways. The presence of both chloro and fluoro groups introduces specific interactions with biological targets, enhancing binding affinity and selectivity. This structural motif has been explored in the design of compounds with antimicrobial, anti-inflammatory, and anticancer properties.

Recent advancements in computational chemistry and molecular modeling have facilitated a deeper understanding of the interactions between 4-(3,5-Dichlorophenyl)-2-fluorobenzaldehyde and biological receptors. Studies have demonstrated that the electron-withdrawing nature of the chloro substituents increases the electrophilicity of the aldehyde group, facilitating nucleophilic addition reactions that are crucial for further derivatization. Additionally, the fluorine atom introduces hydrophobicity and modulates metabolic stability, which are critical factors in drug design.

In the realm of medicinal chemistry, 4-(3,5-Dichlorophenyl)-2-fluorobenzaldehyde has been utilized as a precursor in the synthesis of small-molecule inhibitors targeting enzymes involved in cancer progression. For instance, research has shown that derivatives of this compound exhibit inhibitory activity against kinases such as tyrosine kinases and serine/threonine kinases, which are aberrantly activated in many cancers. The dichlorophenyl moiety enhances binding to these enzymes by forming multiple hydrogen bonds and hydrophobic interactions with key residues in the active site.

The fluorine substituent plays a pivotal role in modulating the pharmacokinetic properties of derived compounds. Fluorine atoms are known to improve metabolic stability by resisting oxidative degradation by cytochrome P450 enzymes. This property is particularly advantageous for drugs that require prolonged half-lives to maintain efficacy. Furthermore, fluorine atoms can influence receptor binding affinity through their ability to engage in weak hydrogen bonding interactions, thereby fine-tuning ligand-receptor affinity.

Recent clinical trials have highlighted the potential of compounds derived from 4-(3,5-Dichlorophenyl)-2-fluorobenzaldehyde in treating inflammatory diseases. Researchers have synthesized analogs that demonstrate potent anti-inflammatory effects by inhibiting cyclooxygenase (COX) enzymes and other pro-inflammatory mediators. The structural rigidity provided by the aromatic ring system allows for precise tuning of biological activity, enabling the development of selective inhibitors with reduced side effects.

The synthesis of 4-(3,5-Dichlorophenyl)-2-fluorobenzaldehyde involves multi-step organic transformations that highlight its synthetic versatility. Common synthetic routes include Friedel-Crafts acylation followed by halogenation and fluorination steps. Advances in green chemistry have also led to more sustainable methods for producing this compound, utilizing catalytic processes that minimize waste and energy consumption.

The applications of 4-(3,5-Dichlorophenyl)-2-fluorobenzaldehyde extend beyond pharmaceuticals into agrochemicals and material science. In agrochemical research, derivatives of this compound have shown promise as intermediates for developing novel pesticides with enhanced efficacy and environmental safety. The unique combination of substituents allows for tailored biological activity against target pests while minimizing toxicity to non-target organisms.

Molecular dynamics simulations have provided insights into the conformational flexibility of 4-(3,5-Dichlorophenyl)-2-fluorobenzaldehyde, revealing how different substituents influence its three-dimensional structure. These studies are crucial for understanding how structural changes impact biological activity, guiding medicinal chemists in optimizing lead compounds for drug development.

The future prospects for 4-(3,5-Dichlorophenyl)-2-fluorobenzaldehyde are promising, with ongoing research exploring its potential in treating neurodegenerative diseases such as Alzheimer's and Parkinson's. Preliminary studies suggest that derivatives of this compound may modulate neurotransmitter receptors involved in these conditions, offering new therapeutic strategies.

In conclusion,4-(3,5-Dichlorophenyl)-2-fluorobenzaldehyde (CAS No. 1361871-90-0) is a versatile intermediate with significant potential in pharmaceutical and agrochemical applications. Its unique structural features enable precise modulation of biological activity, making it a valuable scaffold for drug discovery efforts aimed at treating cancer, inflammation, and neurodegenerative diseases.

• 61072-56-8(4-Chloro-2-fluorobenzaldehyde)
• 96515-79-6(5-Chloro-2-fluorobenzaldehyde)
• 1361761-71-8(2',4'-Dichloro-2-fluoro-biphenyl-4-carboxaldehyde)
• 1178669-83-4(2',3'-Dichloro-3-fluoro-biphenyl-4-carboxaldehyde)
• 1361844-49-6(3',5'-Dichloro-3-fluoro-biphenyl-4-carbonyl chloride)
• 1361710-86-2(3',4'-Dichloro-2-fluoro-biphenyl-3-carboxaldehyde)
• 1381944-68-8(4-(3-chloro-5-fluorophenyl)benzaldehyde)
• 926234-25-5(3',4'-Dichloro-3-fluoro-biphenyl-4-carboxaldehyde)
• 1361778-98-4(3,5-Dichloro-3'-fluoro-4'-methyl-biphenyl)
• 477535-42-5(3,5-Dichloro-2-fluorobenzaldehyde)